Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0767 for dyslipidemia in type 2 diabetes
NCT00547274Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- Jul 2003
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of taranabant in dyslipidemia, sponsored by Merck & Co.. Started Jul 2003; status: terminated.
02
Drugs
taranabant
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00547274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547274.